BIOMAT Database Logo BIOMAT Database Logo

Two patients with cystic fibrosis, nonsense mutations in each cystic fibrosis gene, and mild pulmonary disease. 1990

G R Cutting, and L M Kasch, and B J Rosenstein, and L C Tsui, and H H Kazazian, and S E Antonarakis
Center for Medical Genetics, Johns Hopkins University School of Medicine, Baltimore, MD 21205.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008171 Lung Diseases Pathological processes involving any part of the LUNG. Pulmonary Diseases,Disease, Pulmonary,Diseases, Pulmonary,Pulmonary Disease,Disease, Lung,Diseases, Lung,Lung Disease
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G R Cutting, and L M Kasch, and B J Rosenstein, and L C Tsui, and H H Kazazian, and S E Antonarakis
Mild cystic fibrosis in carriers of two nonsense mutations - a case of genetic compensation response?
September 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,
G R Cutting, and L M Kasch, and B J Rosenstein, and L C Tsui, and H H Kazazian, and S E Antonarakis
Ataluren/ivacaftor combination therapy: Two N-of-1 trials in cystic fibrosis patients with nonsense mutations.
July 2020, Pediatric pulmonology,
G R Cutting, and L M Kasch, and B J Rosenstein, and L C Tsui, and H H Kazazian, and S E Antonarakis
New Pharmacological Approaches to Treat Patients with Cystic Fibrosis with Nonsense Mutations.
November 2016, American journal of respiratory and critical care medicine,
G R Cutting, and L M Kasch, and B J Rosenstein, and L C Tsui, and H H Kazazian, and S E Antonarakis
Two frameshift mutations in the cystic fibrosis gene.
February 1991, American journal of human genetics,
G R Cutting, and L M Kasch, and B J Rosenstein, and L C Tsui, and H H Kazazian, and S E Antonarakis
Nonsense mutations accelerate lung disease and decrease survival of cystic fibrosis children.
November 2023, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,
G R Cutting, and L M Kasch, and B J Rosenstein, and L C Tsui, and H H Kazazian, and S E Antonarakis
Cystic fibrosis gene mutation in two sisters with mild disease and normal sweat electrolyte levels.
December 1991, The New England journal of medicine,
G R Cutting, and L M Kasch, and B J Rosenstein, and L C Tsui, and H H Kazazian, and S E Antonarakis
Pharmacological approaches for targeting cystic fibrosis nonsense mutations.
August 2020, European journal of medicinal chemistry,
G R Cutting, and L M Kasch, and B J Rosenstein, and L C Tsui, and H H Kazazian, and S E Antonarakis
Respiratory epithelial gene expression in patients with mild and severe cystic fibrosis lung disease.
September 2006, American journal of respiratory cell and molecular biology,
G R Cutting, and L M Kasch, and B J Rosenstein, and L C Tsui, and H H Kazazian, and S E Antonarakis
Acute respiratory infection in patients with cystic fibrosis with mild pulmonary impairment: comparison of two physiotherapy regimens.
January 2001, The Australian journal of physiotherapy,
G R Cutting, and L M Kasch, and B J Rosenstein, and L C Tsui, and H H Kazazian, and S E Antonarakis
Nine cystic fibrosis patients homozygous for the CFTR nonsense mutation R1162X have mild or moderate lung disease.
August 1992, Journal of medical genetics,
Copied contents to your clipboard!